Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix's (BDSX) quarterly Short-term Investments came in at $100000.0 in Q2 2022, little changed on a QoQ basis from $100000.0 in Q4 2021.

Biodesix (BDSX) Short-term Investments (2021 - 2022) Analysis & Trends

Biodesix (BDSX) has 2 years of Short-term Investments data on file, last reported at $100000.0 in Q2 2022.

Quarterly Short-term Investments changed N/A year-over-year to $100000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $100000.0 (changed N/A YoY) and the FY2021 annual result came in at $100000.0, changed N/A from the prior year.
Short-term Investments held at $100000.0 in Q2 2022, from $100000.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $100000.0 in Q4 2021 to a low of $100000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Biodesix	292.51 Mn	262.51 Mn	22.04 Mn

Download Data

Date	Value
Jun 30, 2022	100,000.00
Dec 31, 2021	100,000.00